Literature DB >> 8800135

"Hibernating" myocardium: asleep or part dead?

W F Armstrong.   

Abstract

Chronic ischemic dysfunction of the left ventricle is commonly presumed to represent "hibernating" myocardium. The implication of this assumption is that with successful reperfusion, systolic function will improve. Several diagnostic techniques including dobutamine stress echocardiography have been used to detect "viable" myocardium in the setting of chronic left ventricular dysfunction. Predictive accuracies of 70% to 85% have been reported for identifying myocardium that recovers function. Recovery of function has been variable and often dependent on the severity of dysfunction. All current models have presumed that chronically dysfunctioning myocardium is "hibernating." Obviously, in the chronic setting, dysfunction may have many causes and include components of transmural and nontransmural infarction as well as hibernating myocardium. This review focuses on the independent role that nontransmural infarction may play in chronic dysfunction and suggests its impact on diagnostic techniques used to identify hibernating myocardium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800135     DOI: 10.1016/0735-1097(96)00138-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Methodology of a novel myocardial viability protocol.

Authors:  A E Iskandrian; E Acio
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

2.  The search for viable myocardium.

Authors:  R O Bonow
Journal:  West J Med       Date:  1996-12

3.  Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure.

Authors:  D Pagano; R S Bonser; J N Townend; F Ordoubadi; R Lorenzoni; P G Camici
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

4.  Myocardial blood flow at rest and contractile reserve in patients with chronic coronary artery disease and left ventricular dysfunction.

Authors:  J A Panza; V Dilsizian; R V Curiel; E F Unger; J M Laurienzo; A N Kitsiou
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

5.  Correlation between extent of myocardial dysfunction and markers of irreversible damage in failing hearts.

Authors:  R De Maria; L Ruffini; R Testa; M Parolini; M Mangiavacchi; E Vitali; M Merli; G Sambuceti; A Pellegrini; G Baroldi; O Parodi
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

6.  Myocardial perfusion and glucose uptake coupling in CAD patients.

Authors:  Alejandro N Mazzadi; Pierre Croisille; Xavier André-Fouët; Stéphane Fol; Jérôme Duisit; Michel Ovize; Dominique Comar; Marc F Janier
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

7.  Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy.

Authors:  Ankur Pruthi; Ramesh Asopa; Mgr Rajan; Sandip Basu
Journal:  Indian J Nucl Med       Date:  2010-10

8.  Comparison of wall thickening and ejection fraction by cardiovascular magnetic resonance and echocardiography in acute myocardial infarction.

Authors:  Martha Nowosielski; Michael Schocke; Agnes Mayr; Kathrin Pedarnig; Gert Klug; Almut Köhler; Thomas Bartel; Silvana Müller; Thomas Trieb; Otmar Pachinger; Bernhard Metzler
Journal:  J Cardiovasc Magn Reson       Date:  2009-07-09       Impact factor: 5.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.